Cite
MLA Citation
Mark C Genovese et al.. “Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.” Lancet, vol. 391, no. 10139, 2018, pp. 2513–2524. http://access.bl.uk/ark:/81055/vdc_100066553444.0x00004d